Total Visits

Views
DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancer112

Select a period of time:

Views

Views
December 20250
January 20262
February 20260
March 20266
April 20268
May 202610
June 202611
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States22
Netherlands3
United Kingdom2
Turkey2
Colombia2
Chile1
Guatemala1
Libya1
Mali1
Mexico1
 

Top cities views

Views
Los Angeles4
Groningen3
Bogotá2
Ankara1
Bamako1
Chino Hills1
Guatemala City1
Hannibal1
Houston1
Iztacalco1